ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Xiaoqi Mao
Matched on OpenAlex author ID A5053140884. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2023: 1 paper · 2024: 3 papers
Papers 4
- ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis. Co-author DOI 10.1016/j.redox.2024.103200↗
- Pirfenidone alleviates fibrosis by acting on tumour-stroma interplay in pancreatic cancer. Co-author DOI 10.1038/s41416-024-02631-9↗
- NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced autophagy. Co-author DOI 10.1038/s41419-024-06984-0↗
- Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogeneity of PET-CT. Co-author DOI 10.1016/j.csbj.2023.04.003↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Si Shi · 4 shared papers, 2023–2024 · strength 0.80
- Paper ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis. DOI 10.1016/j.redox.2024.103200↗
- Paper Pirfenidone alleviates fibrosis by acting on tumour-stroma interplay in pancreatic cancer. DOI 10.1038/s41416-024-02631-9↗
- Paper NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced auto… DOI 10.1038/s41419-024-06984-0↗
- Mingming Xiao · 3 shared papers, 2024 · strength 0.63
- Paper ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis. DOI 10.1016/j.redox.2024.103200↗
- Paper Pirfenidone alleviates fibrosis by acting on tumour-stroma interplay in pancreatic cancer. DOI 10.1038/s41416-024-02631-9↗
- Paper NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced auto… DOI 10.1038/s41419-024-06984-0↗
- Xianjun Yu · 3 shared papers, 2023–2024 · strength 0.60
- Paper ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis. DOI 10.1016/j.redox.2024.103200↗
- Paper Pirfenidone alleviates fibrosis by acting on tumour-stroma interplay in pancreatic cancer. DOI 10.1038/s41416-024-02631-9↗
- Paper Metabolic reprogramming of cancer-associated fibroblasts in pancreatic cancer contributes to the intratumor heterogenei… DOI 10.1016/j.csbj.2023.04.003↗
- Yalan Lei · 2 shared papers, 2024 · strength 0.42
- Qingcai Meng · 2 shared papers, 2023–2024 · strength 0.39
- Jie Hua · 2 shared papers, 2023–2024 · strength 0.39
- Jin Xu · 2 shared papers, 2023–2024 · strength 0.39
- Xuhui Tong · 1 shared paper, 2024 · strength 0.21
- Di Wu · 1 shared paper, 2024 · strength 0.21
- Xianjun Yu · 1 shared paper, 2024 · strength 0.21
- Mingwei Dong · 1 shared paper, 2024 · strength 0.21
- Jing Yang · 1 shared paper, 2024 · strength 0.21
- H. J. Yang · 1 shared paper, 2024 · strength 0.21
- Zengli Fang · 1 shared paper, 2023 · strength 0.18
- Liang Chen · 1 shared paper, 2023 · strength 0.18
- Rong Tang · 1 shared paper, 2023 · strength 0.18
- Wei Wang · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.